Analysts told Decrypt though ETF approval rumors are adding to optimism, it’s MEI Pharma’s buy-in last month that is really ...

San Diego-based MEI Pharma (NASDAQ:MEIP) has acquired 929,548 Litecoin (CRYPTO: LTC) tokens, becoming the first U.S.-listed ...

MEI Pharma announced its first LTC purchase, sparking a rally for one of the oldest and well-established crypto coins.

Litecoin surges 10% in 24 hours, breaking a 3-year consolidation pattern while gaining prominence as a payment option and ...

Litecoin (LTC) has surged to $119.30 after breaking key resistance at $116, fueled by record transaction volumes and growing ...

There is significant market optimism, with analysts assigning a 90-95% probability that the U.S. SEC will approve a spot ...

Litecoin price surged 12% amid cryptocurrency market’s bounce and mix of LTC catalysts like ETF optimism and institutional ...

MEI Pharma, Inc. (NASDAQ: MEIP) (“MEI” or “the Company”) today announced the acquisition of 929,548 Litecoin (LTC) tokens at an average price of $107.58, successfully launching a major institutional ...

Litecoin trades at $106 post-halving, showing bullish potential despite ETF delay. Key support holds as traders eye future ...

Litecoin (LTC) is once again in the spotlight, holding near the $110 resistance level. If it breaks through $150, it could be ...

LTC technical analysis shows Litecoin testing resistance at $117. A breakout could lead to 14% gains, with $100 as a key level for potential pullback.

Key Points MEI Pharma announced a $100 million private placement to accumulate Litecoin, as well as the addition of Charlie Lee to its board.The timing comes as Bitcoin hovers around an all-time high ...